These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Modifying plasma low-density lipoprotein and high-density lipoprotein cholesterol: what combinations are available in the future? Kastelein JJ Am J Cardiol; 2005 Nov; 96(9A):20K-27K; discussion 34K-35K. PubMed ID: 16291010 [TBL] [Abstract][Full Text] [Related]
5. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management. Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582 [TBL] [Abstract][Full Text] [Related]
6. The treatment of dyslipidemia--what's left in the pipeline? Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M ChemMedChem; 2008 Feb; 3(2):206-21. PubMed ID: 17963209 [TBL] [Abstract][Full Text] [Related]
7. [The role of the high-density lipoprotein (HDL) particle in atherogenesis and potential methods to increase HDL concentrations]. Birjmohun RS; van der Steeg WA; Stroes ES; Kastelein JJ Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2245-50. PubMed ID: 17076358 [TBL] [Abstract][Full Text] [Related]
8. [Favorable effects of decreasing lipids in patients with diabetes mellitus]. Gouni-Berthold I; Krone W Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581 [TBL] [Abstract][Full Text] [Related]
9. Patients with low levels of high-density lipoprotein cholesterol: to treat or not to treat? Tavintharan S; Lim SC; Sum CF Singapore Med J; 2005 Oct; 46(10):519-28. PubMed ID: 16172771 [TBL] [Abstract][Full Text] [Related]
12. Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy. Rosenson RS Am Heart J; 2006 Mar; 151(3):556-63. PubMed ID: 16504615 [TBL] [Abstract][Full Text] [Related]
13. Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease. Barter PJ; Kastelein JJ J Am Coll Cardiol; 2006 Feb; 47(3):492-9. PubMed ID: 16458126 [TBL] [Abstract][Full Text] [Related]
14. Cholesteryl ester transfer protein TaqIB polymorphism in the cholesterol and recurrent events study. Marian AJ Curr Atheroscler Rep; 2005 May; 7(3):178-9. PubMed ID: 15811250 [No Abstract] [Full Text] [Related]
15. The association of apolipoprotein B and low density lipoprotein with cardiovascular risk factors in the Thai population. Krittayaphong R; Chotinaiwatarakul C; Kangkagate C; Bhuripanyo K; Mahanonda N J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S1-7. PubMed ID: 17722296 [TBL] [Abstract][Full Text] [Related]
16. Up with HDL, the "good" cholesterol. Guidelines mainly target LDL cholesterol, but HDL matters, too. Harv Womens Health Watch; 2008 Jun; 15(10):2-3. PubMed ID: 18853517 [No Abstract] [Full Text] [Related]
17. Treatment of high-risk older persons with lipid-lowering drug therapy. Aronow WS Am J Ther; 2008; 15(2):102-7. PubMed ID: 18356628 [TBL] [Abstract][Full Text] [Related]
18. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study. Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708 [TBL] [Abstract][Full Text] [Related]
19. High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease. Brewer HB Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):387-91. PubMed ID: 15003970 [No Abstract] [Full Text] [Related]